靶点针对疾病信息18(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
Insulin-like growth factor I receptor (IGF1R)
INDICATI
Approved Multiple structural anomalies syndrome [ICD-11: LD2F]
INDICATI
Approved Pituitary gland disorder [ICD-11: 5A60-5A61]
INDICATI
Approved Retinopathy [ICD-11: 9B71]
INDICATI
Approved Thyrotoxicosis [ICD-11: 5A02]
INDICATI
Phase 2 Breast cancer [ICD-11: 2C60-2C6Y]
INDICATI
Phase 2 Extraocular muscle disorder [ICD-11: 9C82]
INDICATI
Phase 2 Liver cancer [ICD-11: 2C12]
INDICATI
Phase 2 Lung cancer [ICD-11: 2C25]
INDICATI
Phase 1 Motor neuron disease [ICD-11: 8B60]
INDICATI
Phase 1 Multiple myeloma [ICD-11: 2A83]
INDICATI
Phase 1 Pain [ICD-11: MG30-MG3Z]
INDICATI
Discontinued in Phase 1 Adrenal cancer [ICD-11: 2D11]